JPS6248672B2 - - Google Patents

Info

Publication number
JPS6248672B2
JPS6248672B2 JP54106438A JP10643879A JPS6248672B2 JP S6248672 B2 JPS6248672 B2 JP S6248672B2 JP 54106438 A JP54106438 A JP 54106438A JP 10643879 A JP10643879 A JP 10643879A JP S6248672 B2 JPS6248672 B2 JP S6248672B2
Authority
JP
Japan
Prior art keywords
group
benzothiazole
imidazo
formula
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54106438A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5630990A (en
Inventor
Kyoshi Murase
Toshasu Mase
Kenichi Tomioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP10643879A priority Critical patent/JPS5630990A/ja
Priority to FR8017896A priority patent/FR2463774A1/fr
Priority to DE19803030982 priority patent/DE3030982A1/de
Priority to ES494397A priority patent/ES8106535A1/es
Priority to AT0425280A priority patent/ATA425280A/de
Priority to BE0/201803A priority patent/BE884846A/fr
Priority to IT68303/80A priority patent/IT1166483B/it
Priority to CA000358790A priority patent/CA1158246A/en
Priority to GB8027243A priority patent/GB2056982B/en
Publication of JPS5630990A publication Critical patent/JPS5630990A/ja
Priority to US06/487,357 priority patent/US4497817A/en
Publication of JPS6248672B2 publication Critical patent/JPS6248672B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP10643879A 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation Granted JPS5630990A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP10643879A JPS5630990A (en) 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation
FR8017896A FR2463774A1 (fr) 1979-08-21 1980-08-13 Derives du 2-phenylimidazo(2,1-b)benzothiazole
DE19803030982 DE3030982A1 (de) 1979-08-21 1980-08-16 2-phenylimidazo(2,1-b)benzothiazolderivate
BE0/201803A BE884846A (fr) 1979-08-21 1980-08-20 Derives du 2-phenylimidazo (2,1-b)benzothiazole
AT0425280A ATA425280A (de) 1979-08-21 1980-08-20 Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten
ES494397A ES8106535A1 (es) 1979-08-21 1980-08-20 Un procedimiento de produccion de un derivado de 2-fenilimi-dazo (2,1-b) benzotiazol
IT68303/80A IT1166483B (it) 1979-08-21 1980-08-20 Derivati del 2 fenilimidazo 2 1 b benzotiazolo aventi un effetto immunoregolatorio e procedimento per la loro preparazione
CA000358790A CA1158246A (en) 1979-08-21 1980-08-21 Process of producing 2-phenylimidazo¬2,1-b| benzothiazole derivatives
GB8027243A GB2056982B (en) 1979-08-21 1980-08-21 2 - phenylimidazo(2,1 - b)benzothiazole derivatives
US06/487,357 US4497817A (en) 1979-08-21 1983-04-26 2-Phenylimidazo [2,1-b]benzothiazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10643879A JPS5630990A (en) 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS5630990A JPS5630990A (en) 1981-03-28
JPS6248672B2 true JPS6248672B2 (sr) 1987-10-15

Family

ID=14433638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10643879A Granted JPS5630990A (en) 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation

Country Status (2)

Country Link
JP (1) JPS5630990A (sr)
BE (1) BE884846A (sr)

Also Published As

Publication number Publication date
BE884846A (fr) 1981-02-20
JPS5630990A (en) 1981-03-28

Similar Documents

Publication Publication Date Title
US4497817A (en) 2-Phenylimidazo [2,1-b]benzothiazole derivatives
JPH0670025B2 (ja) ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤
HU179746B (en) Process for producing new spiro-oxasolidines
US4587256A (en) Novel thiazolidine derivatives
US3798226A (en) 3-acylamino-4-phenylquinolines carrying a substituent on the benzene ring
US3506679A (en) 2,5- and 4,5-diarylthiazolyl lower fatty acids and derivatives thereof
US4057641A (en) Method of treating inflammation with 2-(2,3-dihydro-2-isopropyl-4-oxo-4H-1-benzopyran-6-yl)propionic acid
CA2019841C (en) 4,5-dihydro-6h-imidazo[4,5,1-ij]quinolin-6-one-6- oxime-o-sulfonic acid derivatives
US3966783A (en) Compounds
CS214806B2 (en) Method of making the derivatives of the auron
JPH0138791B2 (sr)
JPS6399057A (ja) グリシン誘導体
JPH04360881A (ja) 新規のベンゾセレナゾリノン化合物、これらを調製するプロセスおよびそれらを含む薬剤組成物
US5061713A (en) Analgesic oxazolopyridine compounds
SU1591808A3 (ru) Способ получения замещенных 3-фенил-7н-тиазпло[3,2-ъ] [1,2,4]'· триазин-7-онов и способ получения 2-амино-6н-1,3,4-тиадиазинов
JPS6320237B2 (sr)
US4018798A (en) Substituted (4-oxo-4H-1-benzopyran-2-yl)cyclopropane carboxylic acids and esters
JPS6324498B2 (sr)
JPS6013774A (ja) チアゾリジン誘導体
JPH0450305B2 (sr)
JPS6320236B2 (sr)
JPH0329073B2 (sr)
US3992550A (en) Pharmaceutical compositions containing alryl substituted cyclopenta benzopyrans
OKUTOME et al. 2-Substituted Thiazolines. III.: Reaction with N-Benzoyl-α-amino Acids
HU190736B (en) Process for preparing 7-anilino-isoquinoline-5,8-quinone derivatives